My Treatment Approach to Multiple System Atrophy

被引:12
作者
Coon, Elizabeth A. [1 ]
Ahlskog, J. Eric [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN USA
关键词
NEUROGENIC ORTHOSTATIC HYPOTENSION; CLINICAL-FEATURES; PREDICT SURVIVAL; NATURAL-HISTORY; DOUBLE-BLIND; MIDODRINE; DISEASE; BRAIN; INHIBITION; MANAGEMENT;
D O I
10.1016/j.mayocp.2020.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term management issues are equally challenging and frequently require collaboration with the patient's local care providers. Whereas there is currently no cure for MSA, treatment focuses on the most problematic symptoms experienced by the patient. Autonomic symptoms may include severe orthostatic hypotension with syncope, urinary symptoms culminating in incontinence, constipation, anhidrosis, and erectile dysfunction. Motor symptoms include parkinsonism, cerebellar ataxia, and falls. Although certain motor symptoms may respond partially to medications, some of these medications may exacerbate autonomic problems. In this manuscript, we seek to bridge the gap between tertiary care providers and the patient's local care providers to provide multidisciplinary care to the MSA patient. Patients are often best served by management of their chronic and evolving complex problems with a team approach involving their primary care providers and subspecialists. Treatment guidelines typically list myriad therapeutic options without clarifying the most efficacious and simplest treatment strategies. Herein, we provide a guideline based on what has worked in our MSA clinic, a clinic designed to provide care throughout the disease course with subspecialty integration with the goal of empowering a partnership with the patient's home primary care providers. (C) 2020 Mayo Foundation for Medical Education and Research
引用
收藏
页码:708 / 719
页数:12
相关论文
共 61 条
[1]  
ADAMS RD, 1964, J NEUROPATH EXP NEUR, V23, P584
[2]   Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression [J].
Ahlskog, J. Eric .
MAYO CLINIC PROCEEDINGS, 2018, 93 (03) :360-372
[3]   Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging [J].
Ahlskog, J. Eric ;
Geda, Yonas E. ;
Graff-Radford, Neill R. ;
Petersen, Ronald C. .
MAYO CLINIC PROCEEDINGS, 2011, 86 (09) :876-884
[4]  
[Anonymous], 2015, The New Parkinson's Disease Treatment Book
[5]   Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy [J].
Benarroch, Eduardo E. ;
Schmeichel, Ann M. ;
Low, Phillip A. ;
Parisi, Joseph E. .
BRAIN, 2007, 130 :469-475
[6]   Depressive symptoms and life satisfaction in patients with multiple system atrophy [J].
Benrud-Larson, LM ;
Sandroni, P ;
Schrag, A ;
Low, PA .
MOVEMENT DISORDERS, 2005, 20 (08) :951-957
[7]  
Boesch SM, 2002, J NEUROL NEUROSUR PS, V72, P300, DOI 10.1136/jnnp.72.3.300
[8]   Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 [J].
Bower, JH ;
Maraganore, DM ;
McDonnell, K ;
Rocca, WA .
NEUROLOGY, 1997, 49 (05) :1284-1288
[9]   Chemical pharmacotherapy for the treatment of orthostatic hypotension [J].
Cheshire, William P. .
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) :187-199
[10]   REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century [J].
Claassen, D. O. ;
Josephs, K. A. ;
Ahlskog, J. E. ;
Silber, M. H. ;
Tippmann-Peikert, M. ;
Boeve, B. F. .
NEUROLOGY, 2010, 75 (06) :494-499